AAA
0
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
EndologixCA - Irvine
2 programsAlto Abdominal Stent Graft SystemN/A1 trial
Alto Abdominal Stent Graft SystemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
EndologixAlto Abdominal Stent Graft System
EndologixAlto Abdominal Stent Graft System
Clinical Trials (2)
Total enrollment: 450 patients across 2 trials
JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Start: Dec 2025Est. completion: Dec 20300
N/AWithdrawn
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Start: Sep 2021Est. completion: Mar 2031450 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 450 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.